Journals / Respiratory Case Reports / 2016 / Cilt: 5 - Sayı: 2

Malignant Mesothelioma Diagnosed with Skin Biopsy

Cilt Biyopsisi ile Tanısı Konulan Malign Mezotelyoma Olgusu

Pages
139–143
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we present a case diagnosed with mixed mesothelioma with skin biopsy with skin metastasis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Malignant pleural mesothelioma is a malignant tumor of the pleura.
📊
Key Findings & Data:Diagnosis is made by pleural biopsy.
💡
Conclusion & Impact:Herein, we present a case diagnosed with mixed mesothelioma with skin biopsy with skin metastasis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Malignant pleural mesothelioma is a malignant tumor of the pleura. Diagnosis is made by pleural biopsy. Malignant mesothelioma cases presenting with clinical findings with skin metastasis with a confirmed diagnosis through skin biopsy are extremely rare. Herein, we present a case diagnosed with mixed mesothelioma with skin biopsy with skin metastasis.

Özet

Malign plevral mezotelyoma plevranın kötü huylu tümörüdür. Tanı plevra biyopsi ile konur. Cilt metastazı ile klinik bulgu veren ve cilt biyopsisi ile tanısı konulan mezotelyoma olgusu çok nadirdir. Burada, cilt metastazı ile gelen ve ciltteki lezyondan alınan biyopsi ile mikst tip mezotelyoma tanısı konulan olguyu sunduk.

🔖

Cite This Article

ÖZTÜRK, B., ÇAKMAK, M., DURKAN, A., ONAT, S., ÜLKÜ, R. (2016). Malignant Mesothelioma Diagnosed with Skin Biopsy. Respiratory Case Reports, Cilt: 5 - Sayı: 2, 139–143. https://ajindex.com/articles/302468

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Kalaycı SH, Göktürk SH. Difüz malign mezoteltoma. In: Yüksel M, Balcı AE, eds. İstanbul: Nobel Tıp Kitabevi; 2015:529-39
  2. Stahel RA. Malignant pleural mesothelioma: a new standard of care. Lung cancer 2006; 54(Suppl2):S9-14. [CrossRef] 3. Metintaş M. Mezotelyoma. In: Göksel T, Özlü T, eds. Akciğer ve plevra maligniteleri tedavisi. Ankara: Poyraz Tıbbi Yayıncılık; 2008:78-111
  3. Metintaş M. Mezotelyoma. In: Özlü T, Metintaş M, Karadağ M, Kaya A, eds. Solunum Sistemi ve Hastalıkları. Temel Başvuru Kitabı 1. Baskı. İstanbul: İstanbul Medikal Yayıncılık; 2010:1979-95
  4. Terada T. Skin metastasis of pleural epithelioid malignant mesothelioma. Appl Immunohistochem Mol Morphol 2011; 19:92-3. [CrossRef] 6. Patel T, Bansal R, Trivedi P, Modi L, Shah MJ. Subcutaneous metastases of sarcomatoid mesothelioma with its differential diagnosis on fine needle aspiration--a case report. Indian J Pathol Microbiol 2005; 48:482-4
  5. Eguchi T, Kumeda S. Case of subcutaneous metastasis of malignant pleural mesothelioma. J Japanese Association for Chest Surgery 2007; 21:655-8. [CrossRef] 8. Yüksel M, Batırel H. Mezotelyoma. In: Yüksel M. Kalaycı NG, eds. Göğüs Cerrahisi: İstanbul, Nobel Tıp Kitabevi; 2001:371-81
  6. Harber P, Gee JBL. Clinicans' approach to mesothelioma. In: Pass HI, Vogelzang N, Carbone M, eds. Malignant mesothelioma. New York: Springer; 2005:266-364
  7. Hyland RA, Ware S, Johnson AR, Yates DH. Incidence trends and gender differences in malignant mesothelioma in New South Wales, Australia. Scand J Work Environ Health 2007; 33:286-92. [CrossRef] 11. Marinaccio A, Binazzi A, Cauzillo G, Cavone D, Zotti RD, Ferrante P, et al. Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register. Eur J Cancer 2007; 43:2722-8. [CrossRef] 12. Rusch VW, Diffuse Malignant Mesothelioma. In: Shields TW, LeCicero J, Reed CE, et al, eds. General Thoracic Surgery, 7th ed. Philadelphia: Lipponcott, Williams &Wilkins; 2009:847-59
  8. Anderson KA, Hurley WC, Hurley BT, Ohrt DW. Malignant pleural mesothelioma following radiotherapy in a 76-year-old boy. Cancer 1985; 56:273-6
  9. Lerman Y, Learman Y, Schachter P, Herceg E, Lieberman Y, Yellin A. Radiation associated malignant pleural mesothelioma. Thorax 1991; 46:463-4. [CrossRef] 15. Işık R, Metintaş M, Gibbs AR, Metintaş S, Jasani B, Öner Ü, et al. p53, p21 and metallothionein immunoreactivities in patients with malignant pleural mesothelioma: correlations with the epi